Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pulmonology · Löfgren Syndrome

What Is Löfgren Syndrome in Sarcoidosis?

At a Glance

Löfgren syndrome is an acute, sudden-onset form of sarcoidosis characterized by ankle joint pain, enlarged chest lymph nodes, and tender skin bumps on the shins. Despite the severe initial symptoms, it has an excellent prognosis and typically goes away on its own without aggressive treatments.

Löfgren syndrome is a specific, acute (sudden onset) type of sarcoidosis that, despite its painful and alarming initial symptoms, generally has a very favorable prognosis [1][2]. If your doctor has told you that your sarcoidosis is presenting as Löfgren syndrome, it means you have a distinct form of the disease that is highly likely to go away on its own [3][4].

While most forms of sarcoidosis develop gradually and can sometimes cause long-term organ damage, Löfgren syndrome comes on quickly and typically resolves spontaneously [5][6]. In fact, the symptoms of Löfgren syndrome are so distinct that doctors can often confidently diagnose it without needing to perform a tissue biopsy, which is normally a standard requirement for diagnosing other forms of sarcoidosis [1][7].

The Classic Triad of Symptoms

Löfgren syndrome is traditionally defined by a specific “triad” of three main features, often accompanied by a sudden fever [5][8]:

  • Erythema Nodosum: These are tender, red or purplish, raised bumps that most commonly erupt on the front of the lower legs (shins) [1][9]. While they can look scary and feel very sore, they typically fade away entirely without leaving permanent scars, often just looking like faint bruises as they heal.
  • Bilateral Hilar Lymphadenopathy (BHL): This refers to enlarged lymph nodes on both sides of the chest (the hilum), which are typically discovered when your doctor orders a chest X-ray [5][10].
  • Joint Inflammation (Arthritis/Arthralgia): Patients often experience sudden, painful swelling and stiffness in their joints. In Löfgren syndrome, this most classically affects both ankles (periarthritis), sometimes making it incredibly difficult to walk [11][12].

Some people may not have all three symptoms at the same time—for example, a person might have the joint inflammation and enlarged chest lymph nodes without the skin bumps—but the overall pattern remains highly recognizable to specialists [1][12].

A Favorable Prognosis and Timeline

The onset of Löfgren syndrome can be highly distressing. However, this intense immune reaction is actually a good sign. The robust immune response seen in Löfgren syndrome is associated with a high rate of spontaneous remission (the disease going away on its own) [6][13]. Patients with this presentation are significantly less likely to develop chronic, long-term sarcoidosis compared to those with other forms of the disease [13].

When will the pain stop?
It is important to know that the most agonizing symptoms will not last forever. The severe joint pain, fever, and tender skin bumps usually improve within a few weeks to a couple of months. The enlarged lymph nodes in your chest (visible on X-rays) and the underlying immune response can take one to two years to completely resolve behind the scenes [14][15].

Researchers have discovered that this positive outcome is closely tied to genetics. Löfgren syndrome is strongly associated with specific genetic markers (such as the HLA-DRB1*03 allele) that help the immune system mount an effective, temporary response [14][15].

Managing Symptoms and Follow-up

Because the condition is usually self-limiting, aggressive treatment with heavy, long-term immunosuppressive medications is often unnecessary [14][16]. Instead, care focuses on keeping you comfortable while the worst of the flare subsides.

  • Medications: Pain and inflammation can frequently be managed with standard non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen [1][2]. However, because prolonged NSAID use can carry stomach, kidney, or heart risks, you should take these under your doctor’s supervision. If NSAIDs are not enough to control severe pain, your doctor might prescribe a short course of corticosteroids to help you through the worst of it.
  • At-home care: Resting and elevating your legs can provide significant relief for swollen, painful ankles and tender skin nodules.

Even though Löfgren syndrome has an excellent prognosis, you must still attend follow-up appointments. Your doctor will need to periodically check your symptoms and perform follow-up imaging (like chest X-rays or breathing tests) to confirm that the inflammation is fully resolving and that the disease is not silently progressing.

Common questions in this guide

What are the main symptoms of Löfgren syndrome?
The classic triad of symptoms includes tender red or purplish bumps on the shins (erythema nodosum), enlarged lymph nodes in the chest (bilateral hilar lymphadenopathy), and sudden, painful joint swelling, particularly in the ankles. Patients may also experience a sudden fever.
Do I need a tissue biopsy to diagnose Löfgren syndrome?
Usually, a biopsy is not needed. The combination of sudden ankle joint pain, characteristic skin bumps, and enlarged chest lymph nodes on an X-ray is so distinct that specialists can typically diagnose Löfgren syndrome confidently without a tissue biopsy.
Will Löfgren syndrome go away on its own?
Yes, in most cases. Löfgren syndrome triggers a robust immune response that is associated with a high rate of spontaneous remission. The worst symptoms usually improve within weeks to a few months, though internal inflammation may take one to two years to fully resolve.
How is the pain from Löfgren syndrome treated?
Because the condition usually resolves itself, care focuses on symptom relief. Pain and joint inflammation are typically managed with over-the-counter NSAIDs like ibuprofen or naproxen. If symptoms are severe, your doctor might prescribe a short course of corticosteroids.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my Löfgren syndrome diagnosis, what specific signs or symptoms would indicate that my condition is not resolving on its own and might need further treatment?
  2. 2.Are over-the-counter NSAIDs sufficient to manage my joint pain, or is there a specific prescription or protocol you recommend to keep me comfortable?
  3. 3.At what intervals should we schedule follow-up chest X-rays or breathing tests to monitor my enlarged lymph nodes and ensure the internal inflammation is gone?
  4. 4.Would it be helpful or necessary for me to be genetically tested for the HLA-DRB1*03 marker to confirm my likelihood of spontaneous remission?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Löfgren Syndrome: A Mosaic of Sarcoidosis Phenotypes.

    Martins F, Martins M, Malheiro R

    Cureus 2024; (16(1)):e52317 doi:10.7759/cureus.52317.

    PMID: 38226315
  2. 2

    Löfgren Syndrome: A Case Report and Treatment Challenge.

    Peixoto JM, Leal D, Silva D, Santos L

    Cureus 2024; (16(5)):e59597 doi:10.7759/cureus.59597.

    PMID: 38826917
  3. 3

    [Musculoskeletal manifestations of sarcoidosis].

    Korsten P, Chehab G

    Zeitschrift fur Rheumatologie 2017; (76(5)):408-414 doi:10.1007/s00393-017-0313-5.

    PMID: 28488045
  4. 4

    Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patients.

    Rubio-Rivas M, Corbella X

    European journal of internal medicine 2020; (77()):59-65 doi:10.1016/j.ejim.2020.04.024.

    PMID: 32331839
  5. 5

    Nonlife-Threatening Sarcoidosis.

    Castro MDC, Pereira CAC

    Seminars in respiratory and critical care medicine 2020; (41(5)):733-740 doi:10.1055/s-0040-1710371.

    PMID: 32777854
  6. 6

    Sarcoidosis presenting with and without Löfgren's syndrome: Clinical, radiological and behavioral differences observed in a group of 691patients.

    Rubio-Rivas M, Franco J, Corbella X

    Joint bone spine 2020; (87(2)):141-147 doi:10.1016/j.jbspin.2019.10.001.

    PMID: 31606494
  7. 7

    Current diagnosis and therapy in sarcoidosis.

    Šterclová M

    Vnitrni lekarstvi 2020; (66(7)):409-413.

    PMID: 33380118
  8. 8

    Sarcoid Arthropathy: Comment on the Article by Ungprasert et al.

    Malaviya AN, Kapoor S, Garg S

    Arthritis care & research 2017; (69(2)):310 doi:10.1002/acr.22990.

    PMID: 27390214
  9. 9

    Löfgren Syndrome on 18F-FDG PET/CT: An Acute Manifestation of Sarcoidosis.

    Tol SJM, van der Zant FM, Knol RJJ, et al.

    Clinical nuclear medicine 2022; (47(1)):61-62 doi:10.1097/RLU.0000000000003746.

    PMID: 34874349
  10. 10

    A case of Löfgren's syndrome evaluated by imaging modalities: musculoskeletal ultrasound, MRI and PET-CT.

    Uchida T, Fujikawa K, Kondo A, et al.

    Modern rheumatology case reports 2020; (4(1)):126-130 doi:10.1080/24725625.2019.1681635.

    PMID: 33086958
  11. 11

    Ultrasound characterization of ankle involvement in Löfgren syndrome.

    Goussault C, Albert JD, Coiffier G, et al.

    Joint bone spine 2018; (85(1)):65-69 doi:10.1016/j.jbspin.2017.03.004.

    PMID: 28343011
  12. 12

    Löfgren Syndrome: Clinical Presentation, Clinical Course, and Literature Review.

    Flores R, Caridade S

    Cureus 2023; (15(1)):e33651 doi:10.7759/cureus.33651.

    PMID: 36788849
  13. 13

    Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain.

    Mañá J, Rubio-Rivas M, Villalba N, et al.

    Medicine 2017; (96(29)):e7595 doi:10.1097/MD.0000000000007595.

    PMID: 28723801
  14. 14

    Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with Löfgren's syndrome and other sarcoidosis.

    Karakaya B, Schimmelpennink MC, Kocourkova L, et al.

    Clinical and experimental immunology 2019; (196(2)):249-258 doi:10.1111/cei.13257.

    PMID: 30585624
  15. 15

    Association between sarcoidosis and HLA polymorphisms in a Czech population from Central Europe: focus on a relationship with clinical outcome and treatment.

    Sikorova K, Osoegawa K, Kocourkova L, et al.

    Frontiers in medicine 2023; (10()):1094843 doi:10.3389/fmed.2023.1094843.

    PMID: 37153085
  16. 16

    Bronchoalveolar lavage fluid cell subsets associate with the disease course in Löfgren's and non-Löfgren's sarcoidosis patients.

    Abo Al Hayja M, Wahlström J, Kullberg S, et al.

    Respiratory medicine 2021; (186()):106521 doi:10.1016/j.rmed.2021.106521.

    PMID: 34198166

This page provides educational information about Löfgren syndrome and sarcoidosis. It is not intended to replace professional medical advice, diagnosis, or treatment from your physician.

Get notified when new evidence is published on Sarcoidosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.